Pharma Emerging Markets 2.0: How Emerging Markets Are Driving the Transformation of the Pharmaceutical Industry
Add bookmarkTo better understand both the challenges faced by the global pharmaceutical industry in its pursuit of emerging-market opportunities and the strategies that leaders are employing to address them, Booz & Company surveyed executives from more than 25 of the top pharmaceutical and generics companies, other industry experts, and members of Booz & Company’s global pharmaceutical practice. The results paint a compelling picture of the hurdles and opportunities Pharma faces in pursuing perhaps its best opportunity for growth.
Matthias Buente, Stephan Danner, Susanne Weissbäcker, and Christoph Rammé
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
